CHRISTIN DEMIERRE: Open Payments
NPI 1780123091 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,430 in 121 payments from 16 companies in 2025. Trend: 2023 $687 · 2024 $1,800 · 2025 $2,430
Food & beverage: $2,353Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 47 | $765 |
| ABBVIE INC. | 26 | $454 |
| Aimmune Therapeutics, Inc. | 5 | $213 |
| Celltrion USA Inc. | 9 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $190 |
| VIVUS LLC | 7 | $130 |
| QOL Medical, LLC | 1 | $92 |
| Janssen Scientific Affairs, LLC | 1 | $83 |
| Ardelyx, Inc. | 3 | $79 |
| Gilead Sciences, Inc. | 3 | $55 |
Products named: TREMFYA, LINZESS, VEGZELMA, RINVOQ, PANCREAZE, ZENPEP, ENTYVIO, VOWST.
Industry payments across IL — which companies pay providers there.
